Clinical Trial Update: ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial [Phase 4]

View source ↗

Summary

Clinical trial update for the ESPRIT study (European/Australasian Stroke Prevention in Reversible Ischaemia Trial), a Phase 4 trial focused on stroke prevention…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis
• Brain Ischemia
• Transient Ischemic Attack

Snippet

Sponsor: UMC Utrecht | Conditions: Brain Ischemia, Transient Ischemic Attack | Phase 4 | Status: COMPLETED